Association between CFH single nucleotide polymorphisms and response to photodynamic therapy in patients with central serous chorioretinopathy

被引：0
|
作者：
Dandan Linghu
Hui Xu
Zhiqiao Liang
Tingting Gao
Zhaojun Lin
Xiaoxin Li
Lvzhen Huang
Mingwei Zhao
机构：
[1] Peking University People’s Hospital,Department of Ophthalmology
[2] Eye Diseases and Optometry Institute,College of Optometry
[3] Beijing Key Laboratory of Diagnosis and Therapy of Retina and Choroid Diseases,undefined
[4] Peking University Health Science Center,undefined
来源：
International Ophthalmology | 2020年 / 40卷
关键词：
Single nucleotide polymorphisms; Complement factor H; Verteporfin photodynamic therapy; Central serous chorioretinopathy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：951 / 956
页数：5
相关论文
共 50 条
  • [31] Clinical characteristics of chronic central serous chorioretinopathy patients with insufficient response to reduced-settings photodynamic therapy
    van Rijssen, Th. J.
    van Dijk, E. H. C.
    Dijkman, G.
    Boon, C. J. F.
    [J]. ACTA OPHTHALMOLOGICA, 2018, 96 : 29 - 29
  • [32] Clinical characteristics of chronic central serous chorioretinopathy patients with insufficient response to reduced-settings photodynamic therapy
    van Rijssen, T. J.
    van Dijk, E. H. C.
    Dijkman, G.
    Boon, C. J. F.
    [J]. ACTA OPHTHALMOLOGICA, 2018, 96 : 30 - 31
  • [33] Aniseikonia after reduced-fluence photodynamic therapy in patients with central serous chorioretinopathy
    Chubachi-Kamimura, Aya
    Miki, Akiko
    Hayashida-Hirano, Mayuka
    Kishimoto-Kishi, Maya
    Okuda, Mina
    Matsumiya, Wataru
    Imai, Hisanori
    Kusuhara, Sentaro
    Nakamura, Makoto
    [J]. SCIENTIFIC REPORTS, 2023, 13 (01):
  • [34] Clinical characteristics of chronic central serous chorioretinopathy patients with insufficient response to reduced-settings photodynamic therapy
    van Rijssen, Thomas J.
    van Dijk, Elon H. C.
    Dijkman, Greet
    Boon, Camiel J. F.
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2018, 256 (08) : 1395 - 1402
  • [35] Clinical characteristics of chronic central serous chorioretinopathy patients with insufficient response to reduced-settings photodynamic therapy
    van Rijssen, Thomas Jurian
    Van Dijk, Elon H.
    Dijkman, Greet
    Boon, Camiel
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [36] Long-term visual outcomes of photodynamic therapy in patients with central serous chorioretinopathy
    Bejjani, Romy
    Singhanetr, Panisa
    Rossin, Elizabeth
    Vavvas, Demetrios
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [37] Aniseikonia after reduced-fluence photodynamic therapy in patients with central serous chorioretinopathy
    Aya Chubachi-Kamimura
    Akiko Miki
    Mayuka Hayashida-Hirano
    Maya Kishimoto-Kishi
    Mina Okuda
    Wataru Matsumiya
    Hisanori Imai
    Sentaro Kusuhara
    Makoto Nakamura
    [J]. Scientific Reports, 13 (1)
  • [38] Treatment of choroidal neovascularization in central serous chorioretinopathy by photodynamic therapy with verteporfin
    Chan, WM
    Lam, DSC
    Lai, TYY
    Yuen, KSC
    Liu, DTL
    Chan, CKM
    Chen, WQ
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2003, 136 (05) : 836 - 845
  • [39] Real world outcomes of photodynamic therapy for chronic central serous chorioretinopathy
    Samir Khandhadia
    Suresh Thulasidharan
    Nguyen Thuy Vy Hoang
    Sameh Alkhalili Ibrahim
    Yanling Ouyang
    Andrew Lotery
    [J]. Eye, 2023, 37 : 2548 - 2553
  • [40] Low-fluence photodynamic therapy for acute central serous chorioretinopathy
    Znaor, L.
    Shahrezaei, S. Ansari
    Binder, S.
    [J]. SPEKTRUM DER AUGENHEILKUNDE, 2010, 24 (05) : 271 - 274
12345